Why the study?
Despite reported high in-hospital mortality for STEMI in Sub-Saharan Africa, follow-up data in these patients are scarce.
Does revascularization improve mortality and nonfatal cardiovascular complications in patients with STEMI in a Sub-Saharan African population?
Does revascularization improve mortality and nonfatal cardiovascular complications in patients with STEMI in a Sub-Saharan African population?
Answers are grounded in this paper and cite their sources.
In a Sub-Saharan African cohort of STEMI patients, revascularization was associated with significantly lower all-cause mortality over a median follow-up of 39 months.
BACKGROUND: Major in-hospital mortality rate in patients with ST-segment Elevation Myocardial Infarction (STEMI) in Sub-Saharan Africa has been reported. Data on follow-up in these patients with STEMI are scarce. We aimed to assess medium and long-term prognosis in patients with STEMI admitted to Abidjan Heart Institute. METHODS: Prospective cohort study including 260 patients admitted for STEMI to Abidjan Heart Institute, from January 1, 2012 to December 31, 2015. We compared mortality and nonfatal cardiovascular complications in revascularized and non-revascularized groups. Survival curve was generated with the Kaplan-Meier method. Predictors of mortality after STEMI were determined by multivariable Cox regression. RESULTS: Of the 260 patients followed up on a median period of 39 months [28-68 months], 94 patients (36.1%) were revascularized and 166 (63.8%) were non-revascularized. Crude all-cause mortality was 10.4%. It was significantly higher in non-revascularized patients (p = 0.04). There was no difference in the occurrence of nonfatal cardiovascular complications in the 2 groups. In multivariable Cox regression, age ≥ 70 years, female gender and heart failure were the predictive factors for death after adjustment. CONCLUSIONS: STEMI remains an important cause of mortality in our practice. Healthcare policies should be developed to improve patient care and long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: